Curated News
By: NewsRamp Editorial Staff
July 08, 2025
Image Protect's InterceptCS™ Targets $3.5B Cold Sore Market with Innovative Prevention
TLDR
- Image Protect's InterceptCS™ offers a unique advantage in the cold sore prevention market with its Health Canada-approved, non-drug thermal therapy device, targeting a $3.5 billion global market.
- InterceptCS™ operates as a Class II Medical Device in Canada, using thermal therapy during the prodrome stage to prevent cold sores, with a strategic multi-channel sales approach.
- InterceptCS™ provides a safe, non-drug alternative for cold sore prevention, improving quality of life for millions globally by addressing an underserved health need.
- Discover InterceptCS™, a groundbreaking thermal therapy device that prevents cold sores before they start, now expanding globally through ecommerce and Amazon.
Impact - Why it Matters
This news is significant for individuals suffering from cold sores, offering a new, non-drug prevention method that could improve quality of life. For investors, Image Protect's strategic entry into the wellness technology market represents a potential growth opportunity, with the company setting ambitious revenue targets and leveraging a multi-channel sales approach. The development of InterceptCS™ and its approval by Health Canada underscore the potential for innovation in personal wellness solutions.
Summary
Image Protect, Inc. (OTC:IMTL) has announced significant progress for its subsidiary, Global Wellness Products, following the launch of the InterceptCS™ Cold Sore Prevention System. This innovative product, classified as a Class II Medical Device by Health Canada, offers a non-drug solution for preventing cold sores, targeting a global market estimated at over $3.5 billion annually. The company is leveraging a multi-channel sales strategy, including direct ecommerce and platforms like Amazon, to make InterceptCS™ widely accessible. With ambitious revenue goals and a comprehensive marketing plan, Image Protect aims to establish InterceptCS™ as a leading brand in the wellness technology space.
The company's strategy includes expanding into key international markets and developing a recurring revenue model through the sale of thermal activators. CEO Frank Casella highlighted the potential of InterceptCS™ to meet the needs of millions of cold sore sufferers in North America, emphasizing the product's unique position in the market. Image Protect's commitment to innovation and growth is evident in its strategic planning and marketing efforts, which include social media campaigns, influencer outreach, and search engine marketing. The company's forward-looking statements outline a vision for sustainable growth and long-term value creation for shareholders.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Image Protect's InterceptCS™ Targets $3.5B Cold Sore Market with Innovative Prevention
